Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Remestemcel-L-rknd for Steroid-Refractory Acute Graft-vs-Host Disease in Pediatric Patients.
Journal: JAMA
Published: May 21, 2025
Remestemcel-L (Ryoncil) for graft-versus-host disease.
Journal: The Medical letter on drugs and therapeutics
Published: February 13, 2025
A milestone for the therapeutic EV field: FDA approves Ryoncil, an allogeneic bone marrow-derived mesenchymal stromal cell therapy.
Journal: Extracellular vesicles and circulating nucleic acids
Published: January 02, 2025
Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease Using Commercial Mesenchymal Stem Cell Products.
Journal: Frontiers in immunology
Published: June 13, 2021
Comparative Effectiveness of Remestemcel-L-rknd versus Ruxolitinib in Pediatric Patients with Steroid-Refractory Acute Graft-Versus-Host Disease using Simulated Treatment Comparisons.
Journal: Journal of health economics and outcomes research
Published: March 26, 2021
Showing 1-8 of 8
Last Updated: 10/31/2025